Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INNOVATE (VATE) Other Accumulated Expenses: 2009-2025

Historic Other Accumulated Expenses for INNOVATE (VATE) over the last 15 years, with Sep 2025 value amounting to $17.0 million.

  • INNOVATE's Other Accumulated Expenses rose 4.29% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year increase of 4.29%. This contributed to the annual value of $17.2 million for FY2024, which is 6.83% up from last year.
  • Per INNOVATE's latest filing, its Other Accumulated Expenses stood at $17.0 million for Q3 2025, which was down 1.16% from $17.2 million recorded in Q2 2025.
  • In the past 5 years, INNOVATE's Other Accumulated Expenses ranged from a high of $24.7 million in Q1 2023 and a low of $14.2 million during Q1 2021.
  • In the last 3 years, INNOVATE's Other Accumulated Expenses had a median value of $17.1 million in 2023 and averaged $17.4 million.
  • The largest annual percentage gain for INNOVATE's Other Accumulated Expenses in the last 5 years was 41.86% (2021), contrasted with its biggest fall of 99.69% (2021).
  • Over the past 5 years, INNOVATE's Other Accumulated Expenses (Quarterly) stood at $18.3 million in 2021, then climbed by 9.84% to $20.1 million in 2022, then fell by 19.90% to $16.1 million in 2023, then rose by 6.83% to $17.2 million in 2024, then grew by 4.29% to $17.0 million in 2025.
  • Its Other Accumulated Expenses was $17.0 million in Q3 2025, compared to $17.2 million in Q2 2025 and $17.3 million in Q1 2025.